Uri Barash

1.4k total citations
35 papers, 1.1k citations indexed

About

Uri Barash is a scholar working on Cell Biology, Molecular Biology and Hematology. According to data from OpenAlex, Uri Barash has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cell Biology, 29 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Uri Barash's work include Proteoglycans and glycosaminoglycans research (31 papers), Glycosylation and Glycoproteins Research (20 papers) and Fibroblast Growth Factor Research (18 papers). Uri Barash is often cited by papers focused on Proteoglycans and glycosaminoglycans research (31 papers), Glycosylation and Glycoproteins Research (20 papers) and Fibroblast Growth Factor Research (18 papers). Uri Barash collaborates with scholars based in Israel, United States and Sweden. Uri Barash's co-authors include Israël Vlodavsky, Neta Ilan, Victoria Cohen‐Kaplan, Ralph D. Sanderson, Ilanit Boyango, Inna Naroditsky, Yaniv Zohar, Gil Arvatz, Hien M. Nguyen and Edward Hammond and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Uri Barash

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uri Barash Israel 20 705 642 189 158 151 35 1.1k
Svetlana Gingis‐Velitski Israel 19 917 1.3× 742 1.2× 247 1.3× 177 1.1× 105 0.7× 25 1.3k
Jin-Ping Lai United States 15 545 0.8× 248 0.4× 212 1.1× 172 1.1× 34 0.2× 17 899
Rajiv D. Kalraiya India 18 530 0.8× 177 0.3× 82 0.4× 330 2.1× 86 0.6× 31 781
Marjo Jauhiainen Finland 9 301 0.4× 245 0.4× 309 1.6× 184 1.2× 32 0.2× 11 736
S. Park-Snyder United States 10 492 0.7× 117 0.2× 82 0.4× 167 1.1× 49 0.3× 10 784
Ruzanna Atoyan United States 14 772 1.1× 155 0.2× 241 1.3× 72 0.5× 117 0.8× 21 1.1k
M S Sy United States 16 402 0.6× 315 0.5× 155 0.8× 518 3.3× 34 0.2× 29 1.1k
Alexander Buffone United States 13 319 0.5× 103 0.2× 73 0.4× 222 1.4× 66 0.4× 17 565
Fumiaki Nakayama Japan 16 410 0.6× 71 0.1× 206 1.1× 240 1.5× 35 0.2× 30 803
Ashfaq A. Parkar United States 9 294 0.4× 262 0.4× 78 0.4× 78 0.5× 17 0.1× 12 612

Countries citing papers authored by Uri Barash

Since Specialization
Citations

This map shows the geographic impact of Uri Barash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Barash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Barash more than expected).

Fields of papers citing papers by Uri Barash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Barash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Barash. The network helps show where Uri Barash may publish in the future.

Co-authorship network of co-authors of Uri Barash

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Barash. A scholar is included among the top collaborators of Uri Barash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Barash. Uri Barash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barash, Uri, Inna Naroditsky, Marina Weissmann, et al.. (2024). Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization. Cell Death and Disease. 15(12). 894–894. 1 indexed citations
2.
Li, Li, Uri Barash, Neta Ilan, et al.. (2024). A New Synthesized Dicarboxylated Oxy-Heparin Efficiently Attenuates Tumor Growth and Metastasis. Cells. 13(3). 211–211. 8 indexed citations
3.
Barash, Uri, et al.. (2023). Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation. Cell Death and Disease. 14(7). 465–465. 9 indexed citations
4.
Boer, Casper de, Zachary Armstrong, Uri Barash, et al.. (2022). Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo. Proceedings of the National Academy of Sciences. 119(31). e2203167119–e2203167119. 27 indexed citations
5.
Barash, Uri, Shobith Rangappa, Chakrabhavi Dhananjaya Mohan, et al.. (2021). New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis. Cancers. 13(12). 2959–2959. 15 indexed citations
6.
Zhang, Xiao, P.W. O’Callaghan, Honglian Li, et al.. (2021). Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease. Acta Neuropathologica Communications. 9(1). 84–84. 14 indexed citations
7.
Vlodavsky, Israël, Uri Barash, Hien M. Nguyen, Shiming Yang, & Neta Ilan. (2021). Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis. Seminars in Thrombosis and Hemostasis. 47(3). 240–253. 29 indexed citations
8.
Rogers, Joseph M., Ganga B. Vamisetti, Ido Livneh, et al.. (2020). In vivo modulation of ubiquitin chains by N -methylated non-proteinogenic cyclic peptides. RSC Chemical Biology. 2(2). 513–522. 22 indexed citations
9.
Vlodavsky, Israël, Uri Barash, Giuseppe Roscilli, et al.. (2019). Novel N-acetyl-Glycol-split heparin biotin-conjugates endowed with anti-heparanase activity. European Journal of Medicinal Chemistry. 186. 111831–111831. 12 indexed citations
10.
Barash, Uri, Pei Liu, Euvgeni Vlodavsky, et al.. (2019). Heparanase promotes glioma progression via enhancing CD24 expression. International Journal of Cancer. 145(6). 1596–1608. 34 indexed citations
11.
Bhattacharya, Udayan, Lilach Gutter-Kapon, Ilanit Boyango, et al.. (2019). Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth. Cancer Research. 80(1). 57–68. 38 indexed citations
12.
Mohan, Chakrabhavi Dhananjaya, Habbanakuppe D. Preetham, Shobith Rangappa, et al.. (2019). Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds. iScience. 15. 360–390. 79 indexed citations
13.
Kundu, Soumi, Di Yu, Tommie Olofsson, et al.. (2017). Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth. Molecular Cancer Therapeutics. 16(8). 1705–1716. 30 indexed citations
14.
Mohan, Chakrabhavi Dhananjaya, Shobith Rangappa, Daniel J. Mason, et al.. (2017). Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity. BMC Cancer. 17(1). 235–235. 45 indexed citations
15.
Boyango, Ilanit, Uri Barash, Liat Fux, et al.. (2017). Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis. Matrix Biology. 65. 91–103. 32 indexed citations
16.
Feld, Sari, Ilana Doweck, Gera Neufeld, et al.. (2016). Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth. Cancer Research. 76(9). 2791–2801. 35 indexed citations
17.
Boyango, Ilanit, Uri Barash, Inna Naroditsky, et al.. (2014). Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis. Cancer Research. 74(16). 4504–4514. 61 indexed citations
18.
Barash, Uri, Gil Arvatz, Inna Naroditsky, et al.. (2012). Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody. PLoS ONE. 7(12). e51494–e51494. 10 indexed citations
19.
Arad, Gila, Revital Levy, Dalia Hillman, et al.. (2011). Binding of Superantigen Toxins into the CD28 Homodimer Interface Is Essential for Induction of Cytokine Genes That Mediate Lethal Shock. PLoS Biology. 9(9). e1001149–e1001149. 104 indexed citations
20.
Barash, Uri, et al.. (2010). Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS Journal. 277(19). 3890–3903. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Svetlana Gingis‐Velitski Breakdown of academic impact, for papers by Jin-Ping Lai Breakdown of academic impact, for papers by Rajiv D. Kalraiya Breakdown of academic impact, for papers by Marjo Jauhiainen Breakdown of academic impact, for papers by S. Park-Snyder Breakdown of academic impact, for papers by Ruzanna Atoyan Breakdown of academic impact, for papers by M S Sy Breakdown of academic impact, for papers by Alexander Buffone Breakdown of academic impact, for papers by Fumiaki Nakayama Breakdown of academic impact, for papers by Ashfaq A. Parkar
Rankless by CCL
2026